With box warnings

Without box warnings

Branded

Generic

3 results

rituxan
(rituximab)
Genentech, Inc.
Usage: RITUXAN is indicated for the treatment of various conditions including Non-Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), and Pemphigus Vulgaris (PV) in adults and pediatric patients, as specified.
ruxience
(rituximab-pvvr)
Pfizer Laboratories Div Pfizer Inc
Usage: RUXIENCE is indicated for adult patients with relapsed or refractory non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), and granulomatosis with polyangiitis and microscopic polyangiitis, often in combination with other therapies, depending on the specific condition and patient response.
tavneos
(avacopan)
ChemoCentryx, Inc.
Usage: TAVNEOS is indicated as an adjunctive treatment for adults with severe active ANCA-associated vasculitis (granulomatosis with polyangiitis or microscopic polyangiitis) in conjunction with standard therapy, including glucocorticoids, which it does not replace.

Medications for Granulomatosis With Polyangiitis

rituxan